Eui Jae Sung

Veterinary Clinical Pathologist II @ Altasciences

About

Board-certified veterinary clinical pathologist with industry experience in nonclinical drug safety assessment, including clinical pathology data interpretation, integrated safety assessment, and sponsor-facing reporting across preclinical studies.

Country

United States

City

Washington DC-Baltimore Area

Industry

Biotechnology

Skill

Western Blotting, Cell Biology, PCR, Biochemistry, Assay Development, Cell, Immunohistochemistry, qPCR, Fluorescence Microscopy, Molecular Cloning, High Throughput Screening, Flow Cytometry, FACS analysis, RNAi, Cell Culture, Cell Migration, PowerPoint, Microsoft Excel, Critical Thinking, Free Thinking

Experience

Veterinary Clinical Pathologist II

Altasciences

2025-12 - 2026-4 · 5 mos

United States

Clinical Pathologist 2

Charles River Laboratories

2021-8 - 2024-9 · 3 yrs 2 mos

Ashland, Ohio, United States

- Publication/preparation of clinical pathology reports in preclinical toxicology studies in rodents, NHPs, dogs, rabbits, and minipigs (8-10 clinical pathology reports/month) - Consultation and Education for Study Directors for aiding Clinical Pathology Parameter Interpretation and Evaluation. - Clinical pathology lab support. (Method Validation/Development and Training for Lab staffs)

Clinical pathology fellow

National Institute of Environmental Health Sciences (NIEHS)

2016-6 - 2021-10 · 5 yrs 5 mos

Raleigh-Durham, North Carolina Area

- Veterinary Clinical Pathology & Toxicologic Pathology Training. - Participated in Pathology Working Group for NTP and EPA projects. - Participated in a detection platform development for an early kidney damage marker, Cystatin C. - Investigation of Strain Susceptibility Differences: Evaluating Moribund Status, Histopathology and Serum Biomarkers of Cardiac Injury in three different strains, Male B6C3F1/J mice and their parental strains C3H/HeJ (paternal) and C57BL/6J (maternal)

Postdoctoral Fellow

National Institute of Environmental Health Sciences (NIEHS)

2013-4 - 2021-10 · 8 yrs 7 mos

Raleigh-Durham, North Carolina Area

- Established the Drosophila S2 & S3 cell lines that expressed a stable, genetically encoded calcium indicator, GCaMP3. - Demonstrated a novel Drosophila cytokine, growth-blocking peptide (GBP), that acts through the phospholipase C (PLC)/Ca2+ signaling cascade to mediate the secretion of a ligand for platelet-derived growth factor and vascular endothelial growth factor-receptor (Pvr) homologue. - Determined GBP was a ligand for the orphan G protein coupled receptor, Methuselah-like receptor-10 (Mthl10). - Demonstrated how longevity of the fly (i.e., the organism) was linked to immunological, metabolic and stress-protective responses by genetically manipulating the GBP/Mthl10 connection in larvae and adults.

PHD Student

North Carolina State University

2008-8 - 2013-4 · 4 yrs 9 mos

Raleigh-Durham, North Carolina Area

- Specialized in leukocyte biology and innate immune system regulation - Investigated the role of Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) protein in cell signaling, inflammation, and innate immunity. - Gained in-depth knowledge of dysregulated signal transduction and its impact on inflammatory diseases. - Engaged with the North Carolina State University Center for Comparative Medicine and Translational Research (CCMTR), strengthened interest in bridging fundamental research with clinical applications.